ASST FBF-Sacco Ospedale dei Bambini "V.Buzzi"
- Address
- lock Available on a paid plan
Congenital and Neonatal Diseases
At ASST FBF-Sacco Ospedale dei Bambini "V.Buzzi" in Milan, the Neonatology team is studying congenital, hereditary, and neonatal diseases, with a focus on hypoxic-ischemic encephalopathy in newborns. This research is aimed at improving early treatment and reducing the risk of long-term brain and developmental complications after birth-related asphyxia.
- Hypoxic-ischemic encephalopathy in newborns with signs of asphyxia
- Testing whether early supportive therapy can improve survival and neurodevelopmental outcomes
- Evaluating treatment effectiveness alongside standard neonatal care
These trials explore whether adding a new therapy to current newborn care can lower the chances of death or severe developmental impairment in early childhood.
Digestive System Diseases
The site is also involved in research on digestive system diseases, especially Crohn’s disease, inflammatory bowel diseases, and ulcerative colitis in pediatric participants. The goal is to assess a new treatment approach that may help control inflammation and improve disease management in children.
- Crohn’s disease in children
- Ulcerative colitis and chronic ulcerative colitis
- Studying a therapy intended to improve symptom control and treatment response
This research focuses on whether the investigational treatment can offer better effectiveness for pediatric patients living with chronic bowel inflammation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Eli Lilly & Co.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ASST FBF-Sacco Ospedale dei Bambini "V.Buzzi"
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase III, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of N-Acetyl-L-Leucine in Patients with CACNA1A Disorders | IntraBio Inc, Intrabio Limited | Phase III | Recruiting | Aug 2026 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| L-Acetylleucine | 1 | Unknown | 2026-08-11 | 2026-08-11 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.